drugset / Trial / NCT07085468
A Study of LY3549492 in Healthy Weight Adult Participants
RandomizedParallel-groupDouble-blindBasic science
Summary
The main purpose of this study is to evaluate the safety and tolerability of LY3549492 in adult participants with a healthy body max index (BMI) of 22 to 25 kilograms per square meter (kg/m2). Participation in the study will last about 13 months.
Timeline
- Start
- 2025-07-21
- Primary completion
- 2025-08-14
- Completion
- 2025-08-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LY3549492 | Unknown | — | Oral |
Indications
No indication recorded.